Plain-English translation of NCT04887623 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that tracks hospitalized COVID-19 patients to measure how infection and inflammation markers change during their hospital stay and recovery. Researchers will collect blood samples and other clinical information at different time points to better understand the course of moderate to severe COVID-19 infection.
Doctors need better ways to measure how severely infected a COVID-19 patient is and how well they are improving. By tracking specific markers of infection and inflammation over time, researchers hope to identify better indicators of disease severity and recovery.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be admitted to the hospital for your COVID-19 care as usual. Researchers would collect additional blood samples and information about your medical history, medications, and treatments throughout your hospital stay and at follow-up visits on day 28 and day 90 after admission. You would not need to do anything extra beyond standard hospital care.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Czechia
Enrollment target
~30 participants
Started
April 2021
Primary completion
July 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pavel Dostál, MD, PhD
University Hospital Hradec Kralove
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.